Guidelines for the measurement of BCR-ABL1 transcripts in chronic myeloid leukaemia.

Guidelines for the measurement of BCR-ABL1 transcripts in chronic myeloid leukaemia.

Molecular testing for the BCR-ABL1 fusion gene by real time quantitative polymerase chain reaction (RT-qPCR) is the most sensitive routine approach for monitoring the response to therapy of patients with chronic myeloid leukaemia. In the context of tyrosine kinase inhibitor (TKI) therapy, the techni...

ver descrição completa

Detalhes bibliográficos
Principais autores:	Foroni, L, Wilson, G, Gerrard, G, Mason, J, Grimwade, D, White, H, de Castro, D, Austin, S, Awan, A, Burt, E, Clench, T, Farruggia, J, Hancock, J, Irvine, A, Kizilors, A, Langabeer, S, Milner, B, Nickless, G, Schuh, A, Sproul, A, Wang, L, Wickham, C, Cross, N
Formato:	Journal article
Idioma:	English
Publicado em:	2011

Registros relacionados

Consensus on BCR-ABL1 reporting in chronic myeloid leukaemia in the UK
por: Cross, N, et al.
Publicado em: (2018)

Sequential quantitative minimal residual disease in BCR-ABL positive acute lymphoblastic leukaemia: Differential observations between major and minor fusion gene rearrangements and variation due to source material
por: Gerrard, G, et al.
Publicado em: (2004)

No Benefit of BCR-ABL1 Screening in Polycythemia
por: STEPHEN E. LANGABEER
Publicado em: (2016-07-01)

Targeting BCR-ABL1-positive leukaemias: a review article
por: Steven Leak, et al.
Publicado em: (2023-01-01)

The FABD domain is critical for the oncogenicity of BCR/ABL in chronic myeloid leukaemia
por: Renren Zheng, et al.
Publicado em: (2024-06-01)

Rapid Evolution to Blast Crisis Associated with a Q252H ABL1 Kinase Domain Mutation in e19a2 BCR-ABL1 Chronic Myeloid Leukaemia
por: Sarah L. McCarron, et al.
Publicado em: (2013-01-01)

Frequencies of BCR-ABL1 fusion transcripts among Sudanese chronic myeloid leukaemia patients
por: Emad-Aldin I. Osman, et al.
Publicado em: (2010-01-01)

Frequency of the minor BCR-ABL (e1;a2) transcript oncogene in a Mexican population with adult acute lymphoblastic leukaemia
por: I. Olarte-Carrillo, et al.
Publicado em: (2015-07-01)

Cross-talk between Bcr-abl and the Thioredoxin System in Chronic Myeloid Leukaemia: Implications for CML Treatment
por: Erin Clapper, et al.
Publicado em: (2020-03-01)

Leukaemia exposure alters the transcriptional profile and function of BCR::ABL1 negative macrophages in the bone marrow niche
por: Amy Dawson, et al.
Publicado em: (2024-02-01)

Allosteric inhibition enhances the efficacy of ABL kinase inhibitors to target unmutated BCR-ABL and BCR-ABL-T315I
por: Mian Afsar, et al.
Publicado em: (2012-09-01)

FISH-negative BCR::ABL1-positive e19a2 chronic myeloid leukaemia: the most cryptic of insertions
por: Philippa C. May, et al.
Publicado em: (2023-07-01)

No association between BCR-ABL1 fusion genes and clinical features of acute lymphoblastic leukaemia in Ghanaian patients
por: Victor Obeng Ofori, et al.
Publicado em: (2020-10-01)

Peptides spanning the junctional region of both the abl/bcr and the bcr/abl fusion proteins bind common HLA class I molecules.
por: Berke, Z, et al.
Publicado em: (2000)

BCR-ABL1 kinase domain mutation screening using next generation sequencing in CML and Ph plus ALL patients
por: Kizilors, A, et al.
Publicado em: (2019)

Molecular diagnosis of the myeloproliferative neoplasms: UK guidelines for the detection of JAK2 V617F and other relevant mutations.
por: Bench, A, et al.
Publicado em: (2013)

Pterostilbene downregulates BCR/ABL and induces apoptosis of T315I-mutated BCR/ABL-positive leukemic cells
por: Shohei Kawakami, et al.
Publicado em: (2022-01-01)

EVI1 expression in acute myeloid leukaemia.
por: Langabeer, SE, et al.
Publicado em: (2001)

Effect of Ras Inhibition in Hematopoiesis and BCR/ABL Leukemogenesis
por: Baum Karina J, et al.
Publicado em: (2008-06-01)

Monitoring BCR-ABL transcript levels by real-time quantitative polymerase chain reaction: a linear regression equation to convert from BCR-ABL/B2M ratio to estimated BCR-ABL/ABL ratio
por: Ilaria Iacobucci, et al.
Publicado em: (2007-03-01)

Combined targeting of GPX4 and BCR-ABL tyrosine kinase selectively compromises BCR-ABL+ leukemia stem cells
por: Chengwu Zeng, et al.
Publicado em: (2024-10-01)

Co-expression of the CBFβ-MYH11 and BCR-ABL fusion genes in chronic myeloid leukaemia / Coexistenţa genelor de fuziune CBFβ-MYH11 şi BCR-ABL în leucemia mieloidă cronică
por: Popescu Roxana, et al.
Publicado em: (2015-06-01)

Genomic amplification of <it>BCR/ABL1 </it>and a region downstream of <it>ABL1 </it>in chronic myeloid leukaemia: a FISH mapping study of CML patients and cell lines
por: Virgili Anna, et al.
Publicado em: (2010-09-01)

BCR::ABL1-like acute lymphoblastic leukaemia: a single institution experience on identification of potentially therapeutic targetable cases
por: Anna Płotka, et al.
Publicado em: (2023-07-01)

Potential role of Notch signalling in CD34+ chronic myeloid leukaemia cells: cross-talk between Notch and BCR-ABL.
por: Abdullah Aljedai, et al.
Publicado em: (2015-01-01)

Imatinib Resistance in Chronic Myeloid Leukemia Associated with a D363G BCR::ABL1 Kinase Domain Mutation
por: Stephen E. Langabeer, et al.
Publicado em: (2023-01-01)

The other Achilles’ heel of BCR-ABL1
por: Kim De Keersmaecker
Publicado em: (2012-01-01)

An In-house Method for Molecular Monitoring of BCR-ABL
por: Hakkı Ogun Sercan, et al.
Publicado em: (2012-12-01)

Smart applications of bionanosensors for BCR/ABL fusion gene detection in leukemia
por: Karen Y.P.S. Avelino, et al.
Publicado em: (2017-10-01)

p185BCR/ABL has a lower sensitivity than p210BCR/ABL to the allosteric inhibitor GNF-2 in Philadelphia chromosome-positive acute lymphatic leukemia
por: Afsar A. Mian, et al.
Publicado em: (2012-02-01)

The HSP90 inhibitor KW-2478 depletes the malignancy of BCR/ABL and overcomes the imatinib-resistance caused by BCR/ABL amplification
por: Dachuan Zeng, et al.
Publicado em: (2022-05-01)

Association of Clinical Features and Hematological Laboratories between Ph (+)/BCR-ABL (+) Chronic Myeloid Leukemia and Other Type of Ph/BCR-ABL Chronic Myeloid Leukemia
por: Wulyo Rajabto, et al.
Publicado em: (2018-03-01)

Prevalence of atypical BCR-ABL1 transcript types in adult Philadelphia chromosome-positive acute lymphoblastic leukemia: implications for measurable residual disease
por: Úna Bhreathnach, et al.
Publicado em: (2022-01-01)

LMC y detección del gen de fusión BCR/ABL
por: C. G. Artigas Allaire
Publicado em: (2006-04-01)

OCT-1 function varies with cell lineage but is not influenced by BCR-ABL
por: Jane R. Engler, et al.
Publicado em: (2011-02-01)

Detection of ABL1 deletion without BCR-ABL rearrangement in ETP-ALL
por: Ahmed Makboul, et al.
Publicado em: (2024-10-01)

Molecular diagnosis of the myeloproliferative neoplasms: UK guidelines for the detection of JAK2 V617F and other relevant mutations
por: Bench, A, et al.
Publicado em: (2013)

Higher prevalence of harbouring BCR::ABL1 in first-degree relatives of chronic myeloid leukaemia (CML) patients compared to normal population
por: Jew Win Kuan, et al.
Publicado em: (2024-06-01)

Overcoming BCR::ABL1 dependent and independent survival mechanisms in chronic myeloid leukaemia using a multi-kinase targeting approach
por: Caroline Busch, et al.
Publicado em: (2023-11-01)

Bcr-aBL1 kinase domain mutation analysis in chronic myeloid leukaemia patients with suboptimal response to tyrosine kinase inhibitors
por: Tadej Pajič, et al.
Publicado em: (2012-12-01)